Suppr超能文献

探索高流量鼻导管在神经重症监护病房的有效性:一项前瞻性观察研究。

Exploring the effectiveness of high-flow nasal cannula in the neurointensive care unit: a prospective observational study.

作者信息

Nair Shalini, Rajiv M, Job Manoj, Karuppasamy Reka

机构信息

Neuro ICU, Department of Critical Care Medicine, Christian Medical College, Vellore, Tamil Nadu, India.

Neuro ICU, Christian Medical College, Vellore, Tamilnadu, India.

出版信息

BMC Neurol. 2025 Feb 11;25(1):58. doi: 10.1186/s12883-025-04047-1.

Abstract

BACKGROUND

Acute respiratory failure is common occurrence in critical care, with varying causes, depending on case mix of the ICU. High flow nasal cannula (HFNC) is commonly utilized in both adult and pediatric population. However, traditionally, neurologically ill patients have been considered unsuitable for HFNC due to poor sensorium and risk of aspiration. Therefore, we conducted a study to assess the effectiveness of HFNC in Neuro ICU.

METHODOLOGY

We did a prospective observational study on all adult patients requiring HFNC during their stay in Neuro ICU. Primary aim of the study was to find common indications for use of HFNC in neuro ICU. The secondary objective was to observe if HFNC could prevent re-intubation. The various other factors studied included age, gender, diagnosis (traumatic brain injury, postoperative neurosurgical condition or other neurological conditions), GCS score, HFNC settings, duration and cost of HFNC therapy.

RESULTS

During the period from January 1, 2021- 23, out of 1825 patients admitted to neuro ICU, 98 required HFNC therapy. Mean age was 43.3 years (range 18-85), 75.5% of which were males. Utilization rate of HFNC was 5.3%. HFNC was more commonly used for non-trauma patients, most often to reduce work of breathing following extubation (85%). HFNC helped prevent the need for re-intubation in 76.5% of patients with a failure rate of 23.5% across all subgroups of patients in neuro ICU. Requirements for higher flow rate and FiO were significant predictors of HFNC failure. The mean cost of HFNC usage accounted for only 5.6% of the total inpatient bill.

CONCLUSION

In neurocritical care, the causes of extubation failures and hypoxemia, differ significantly from other ICUs. In our study, HFNC was used most often to reduce work of breathing following extubation and was useful in preventing re-intubation. The use of HFNC did not significantly increase the cost of healthcare.

摘要

背景

急性呼吸衰竭在重症监护中很常见,其病因各异,取决于重症监护病房(ICU)的病例组合情况。高流量鼻导管(HFNC)在成人和儿童患者中都普遍使用。然而,传统上,神经系统疾病患者由于意识不清和误吸风险,一直被认为不适合使用HFNC。因此,我们开展了一项研究,以评估HFNC在神经重症监护病房(Neuro ICU)的有效性。

方法

我们对所有在Neuro ICU住院期间需要使用HFNC的成年患者进行了一项前瞻性观察研究。该研究的主要目的是找出在神经重症监护病房使用HFNC的常见适应症。次要目标是观察HFNC是否能预防再次插管。研究的其他各种因素包括年龄、性别、诊断(创伤性脑损伤、神经外科术后情况或其他神经系统疾病)、格拉斯哥昏迷评分(GCS)、HFNC设置、HFNC治疗的持续时间和费用。

结果

在2021年1月1日至23日期间,在1825名入住神经重症监护病房的患者中,有98名需要HFNC治疗。平均年龄为43.3岁(范围18 - 85岁),其中75.5%为男性。HFNC的使用率为5.3%。HFNC更常用于非创伤患者,最常见的用途是在拔管后减轻呼吸负担(85%)。HFNC帮助76.5%的患者避免了再次插管的需要,在Neuro ICU的所有患者亚组中失败率为23.5%。更高流速和吸氧浓度(FiO)的需求是HFNC失败的重要预测因素。HFNC使用的平均费用仅占住院总费用的5.6%。

结论

在神经重症监护中,拔管失败和低氧血症的原因与其他ICU有显著差异。在我们的研究中,HFNC最常用于在拔管后减轻呼吸负担,并且在预防再次插管方面是有效的。使用HFNC并没有显著增加医疗费用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9fa/11816769/2d033aab4c6e/12883_2025_4047_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验